| Manager | Title | Age | Since |
|---|---|---|---|
Kirk Chin Kee
CEO | Chief Executive Officer | 64 | 14/02/2000 |
Woon Wui Chiew
DFI | Director of Finance/CFO | 52 | 31/12/2023 |
Mei Ling Wong
IRC | Investor Relations Contact | - | 31/12/2008 |
| Director | Title | Age | Since |
|---|---|---|---|
Kirk Chin Kee
CHM | Chairman | 64 | 18/05/2010 |
Robert Millner
BRD | Director/Board Member | 75 | 22/02/2000 |
Kirk Chuen Kee
BRD | Director/Board Member | 61 | 17/05/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 07/01/26 | Others | Chief Executive Officer | 5,700,000 | 0.7890% | ||
| 07/01/26 | Others | Chief Executive Officer | 4,035,800 | 0.5586% | ||
| 07/01/26 | Others | Chief Executive Officer | 2,979,372 | 0.4124% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 481M | ||
| -0.68% | +5.50% | +54.23% | +111.17% | 1,120B | ||
| -1.12% | -4.40% | +30.15% | +65.53% | 616B | ||
| -0.80% | +0.78% | +22.08% | +94.68% | 504B | ||
| +0.24% | +5.58% | +35.22% | +59.40% | 367B | ||
| -0.92% | -0.43% | +67.78% | +44.20% | 360B | ||
| -0.40% | +3.53% | +19.26% | +46.55% | 288B | ||
| -0.37% | +3.11% | -1.31% | +18.23% | 258B | ||
| -1.30% | +2.28% | +40.79% | +52.20% | 234B | ||
| -0.88% | +2.76% | +25.56% | +97.07% | 194B | ||
| Average | -0.64% | +3.31% | +32.64% | +65.45% | 437.88B | |
| Weighted average by Cap. | -0.73% | +3.52% | +37.43% | +76.00% |
Employees
-
Sector
Pharmaceuticals
















